ゲノミクスの世界市場規模：技術別、用途別、製品・サービス別、地域別、範囲および予測

ゲノミクスの市場規模と予測

ゲノミクス市場規模は、2023年に447億1,000万米ドルと評価され、2024年～2031年の間に18.90％のCAGRで成長する見込みで、2031年には1,584億5,000万米ドルに達すると予測されます。世界のゲノミクスとは、DNA配列、遺伝子の機能、相互作用など、生物の全遺伝子構成の包括的な研究と分析を指します。個別化医療、農業、バイオテクノロジーなどの分野で重要な役割を果たしています。ヘルスケアでは、ゲノミクスによって個人の遺伝的プロファイルに合わせた精密治療が可能になり、がんや遺伝性疾患などの治療成績が向上します。農業では、遺伝子編集によって作物の回復力と生産性を高めることができます。

世界のゲノミクスの将来は、人工知能とデータ解析の革新によって、遺伝子治療、創薬、持続可能な農業の進歩が約束されています。

世界のゲノミクス市場力学

主な市場促進要因

個別化医療に対する需要の高まり：

個人の遺伝子プロファイルに基づいて治療を調整する個別化医療の採用が増加していることが、主要な促進要因となっています。米国国立衛生研究所によると、2022年に承認される医薬品の約39%が個別化治療です。

ゲノムシークエンシングの技術的進歩：

次世代シークエンシング（NGS）など、シークエンシング技術の絶え間ない革新により、ゲノムシークエンシングのコストは大幅に低下しています。国立ヒトゲノム研究所の報告によると、ヒトゲノムの塩基配列決定コストは、2001年の1億米ドルから2022年には1,000ドルを下回るまでに低下します。

政府の資金援助と研究イニシアティブ：

世界中の政府がゲノム研究に投資しています。例えば米国政府は、ゲノム研究の進展を支援するため、2023年に国立ヒトゲノム研究所に6億米ドルを割り当てました。

遺伝性疾患の有病率の増加：

がんや希少疾患などの遺伝性疾患や障害の増加がゲノム研究の需要を促進しています。世界保健機関（WHO）は、全出生の約10％が遺伝的または部分的な遺伝的疾患の影響を受けているとし、ゲノム診断と治療の必要性を煽っています。

主な課題

ゲノム技術の高コスト：

進歩にもかかわらず、全ゲノム配列決定やデータ解析のような高度なゲノム技術のコストは依然として高く、特に中低所得国での利用が制限されています。

データのプライバシーと倫理的懸念：

センシティブな遺伝情報の保存や共有は、プライバシーや誤用に関する懸念を生じさせ、差別や個人健康データへの不正アクセスの潜在的リスクを伴います。

ゲノムデータ解釈の複雑さ：

ゲノムデータは膨大かつ複雑であるため、所見を正確に解釈する上で課題があり、高度な計算ツールや専門的な知識が必要とされるが、これらは広く普及していないです。

規制と標準化の問題：

世界のゲノミクス市場は、地域によって規制の枠組みが異なることに直面しており、標準化されたプロトコルの欠如は、臨床および研究現場におけるゲノム技術の採用を遅らせる可能性があります。

主要動向：

人工知能（AI）と機械学習の統合：

膨大なゲノムデータの解析にAIと機械学習がますます利用されるようになり、疾病診断や医薬品開発などの分野で精度が向上し、発見が加速されます。

消費者直接ゲノミクスの拡大：

消費者向けゲノム検査を直接提供する公開会社の台頭により、個人が健康、家系、健康増進の目的で自分の遺伝情報にアクセスできるようになり、ゲノミクスへの関心が高まっています。

精密医療への取り組みの拡大：

政府やヘルスケアシステムは、特にがん治療において、個々の患者の遺伝子プロファイルに合わせた個別化治療を開発するためにゲノミクスを利用する精密医療に、より一層注力しています。

CRISPRと遺伝子編集の進歩：

遺伝子編集技術、特にCRISPRは、遺伝子を正確に改変するツールを提供することで、遺伝子治療、農業、バイオテクノロジーにおける新たな可能性を切り開き、ゲノミクスの展望を大きく変えつつあります。

目次

第1章 世界のゲノミクス市場のイントロダクション

• 市場のイントロダクション
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のゲノミクス市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界のゲノミクス市場：技術別

• 概要
• シーケンシング技術
• マイクロアレイ解析
• PCR技術
• CRISPR

第6章 世界のゲノミクス市場：用途別

• 概要
• 診断
• 創薬と開発
• 研究
• 農業と畜産
• 消費者ゲノム

第7章 世界のゲノミクス市場：製品・サービス別

• 概要
• 機器・装置
• 消耗品
• ソフトウェアとサービス

第8章 世界のゲノミクス市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のゲノミクス市場：競合情勢

• 概要
• 各社の市場シェア
• 主な発展戦略

第10章 企業プロファイル

• llumina
• Thermo Fisher Scientific
• Agilent Technologies
• , Danaher Corporation（Beckman Coulter）
• PerkinElmer
• QIAGEN
• BGI Group
• Macrogen
• Oxford Nanopore Technologies

第11章 付録

• 関連調査

Genomics Market Size and Forecast

Genomics Market size was valued at USD 44.71 Billion in 2023 and is projected to reach USD 158.45 Billion by 2031 , growing at a CAGR of 18.90% from 2024 to 2031. Global genomics refers to the comprehensive study and analysis of an organism's entire genetic makeup, including its DNA sequence, gene functions, and interactions. It plays a crucial role in fields such as personalized medicine, agriculture, and biotechnology. In healthcare, genomics enables precision treatments by tailoring therapies to an individual's genetic profile, improving outcomes for diseases like cancer and genetic disorders. In agriculture, it enhances crop resilience and productivity through gene editing.

The future of global genomics promises advancements in gene therapy, drug discovery, and sustainable agriculture, driven by innovations in artificial intelligence and data analytics.

Global Genomics Market Dynamics

The key market dynamics that are shaping the Genomics Market include:

Key Market Drivers:

Rising Demand for Personalized Medicine:

The increasing adoption of personalized medicine, which tailors treatments based on individual genetic profiles, is a major driver. According to the U.S. National Institutes of Health, approximately 39% of medicines approved in 2022 were personalized therapies.

Technological Advancements in Genomic Sequencing:

Continuous innovations in sequencing technologies, such as next-generation sequencing (NGS), have significantly reduced the cost of genome sequencing. The National Human Genome Research Institute reported that the cost of sequencing a human genome dropped from $100 million in 2001 to below $1,000 in 2022.

Government Funding and Research Initiatives:

Governments worldwide are investing in genomic research. For instance, the U.S. government allocated $600 million to the National Human Genome Research Institute in 2023 to support advancements in genomics research.

Increasing Prevalence of Genetic Disorders:

The rise in genetic diseases and disorders, such as cancer and rare diseases, is driving demand for genomic research. The World Health Organization (WHO) states that around 10% of all births are affected by genetic or partially genetic conditions, fueling the need for genomic diagnostics and therapies.

Key Challenges:

High Cost of Genomic Technologies:

Despite advancements, the cost of advanced genomic technologies like whole genome sequencing and data analysis remains high, limiting accessibility, especially in low- and middle-income countries.

Data Privacy and Ethical Concerns:

The storage and sharing of sensitive genetic information raise concerns about privacy and misuse, with potential risks of discrimination or unauthorized access to personal health data.

Complexity of Genomic Data Interpretation:

The sheer volume and complexity of genomic data present challenges in accurately interpreting findings, requiring advanced computational tools and specialized expertise, which are not widely available.

Regulatory and Standardization Issues:

The global genomics market faces varying regulatory frameworks across different regions, and the lack of standardized protocols can delay the adoption of genomic technologies in clinical and research settings.

Key Trends:

Integration of Artificial Intelligence (AI) and Machine Learning:

AI and machine learning are increasingly being used to analyze vast amounts of genomic data, improving accuracy and speeding up discoveries in areas like disease diagnosis and drug development.

Expansion of Direct-to-Consumer Genomics:

The rise of companies offering direct-to-consumer genomic testing has empowered individuals to access their genetic information for health, ancestry, and wellness purposes, driving public interest in genomics.

Growth of Precision Medicine Initiatives:

Governments and healthcare systems are focusing more on precision medicine, using genomics to develop personalized treatments tailored to the genetic profiles of individual patients, especially in cancer care.

CRISPR and Gene Editing Advancements:

Gene editing technologies, especially CRISPR, are transforming the genomics landscape by offering tools to modify genes with precision, opening new possibilities in gene therapy, agriculture, and biotechnology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Genomics Market Regional Analysis

Here is a more detailed regional analysis of the global genomics market:

North America

North America holds the dominant position in the global genomics market, driven by advanced healthcare infrastructure, significant research funding, and a high adoption rate of genomics technologies. The United States, in particular, plays a key role in the region's dominance, with the National Institutes of Health (NIH) allocating over $1.2 billion annually to genomics research. The strong presence of major biotechnology companies and well-established genomic databases further boosts the region's leadership. Moreover, favorable regulatory frameworks and government initiatives like the Precision Medicine Initiative have spurred the growth of personalized genomics in healthcare and research.

The region's robust research environment and cutting-edge technology adoption continue to enhance the genomics market's growth. North America's substantial market share is also attributed to increasing investments in genomic data analysis tools, next-generation sequencing (NGS) technologies, and bioinformatics. As genomics plays a critical role in cancer research, genetic testing, and pharmaceutical development, the region is well-positioned to remain a global leader. The rise in genetic disorder cases and the growing use of genomics in drug development further solidify North America's dominance.

Asia Pacific

Asia Pacific is the fastest-growing region in the global genomics market, fueled by rapid advancements in healthcare infrastructure, government initiatives, and increased investments in research and development. Countries like China, Japan, and India are driving this growth, with China alone projected to see a 12.5% annual growth rate in genomics investments by 2026. The rising awareness of genetic testing and precision medicine, along with the increasing prevalence of chronic diseases, is boosting the demand for genomics-based solutions in the region.

Moreover, government-backed genomics programs like China's Precision Medicine Initiative, which has allocated $9 billion for research, are accelerating the development of genomics in healthcare. In India, the government's Genome India Project aims to map the genetic diversity of over 10,000 individuals, further highlighting the region's focus on genomics research. The growing number of collaborations between local research institutions and global biotechnology companies is also propelling market growth in Asia Pacific, making it a key player in the future of genomics.

Global Genomics Market: Segmentation Analysis

The Global Genomics Market is segmented on the basis of By Technology, By Application, By Product and Services and By Geography.

Genomics Market, By Technology

• Sequencing Technologies
• Microarray Analysis
• PCR
• CRISPR

Based on Technology, the Global Genomics Market is segmented into Sequencing Technologies, Microarray Analysis, PCR, and CRISPR. PCR (polymerase chain reaction), and CRISPR, sequencing technologies are dominating the genomics market due to their widespread application in clinical diagnostics, personalized medicine, and large-scale genomic projects. These technologies, especially next-generation sequencing (NGS), provide comprehensive genetic information with high accuracy. On the other hand, CRISPR is the fastest-growing segment, driven by its revolutionary potential in gene editing, gene therapy, and biotechnology, allowing precise modification of DNA sequences, which is transforming research and therapeutic applications across industries.

Genomics Market, By Application

• Diagnostics
• Drug Discovery and Development
• Research
• Agriculture And Livestock
• Consumer Genomics

Based on Application, the Global Genomics Market is segmented into Diagnostics, Drug Discovery and Development, Research, Agriculture and Livestock, and Consumer Genomics. The Diagnostics segment is dominating the global genomics market, driven by the increasing demand for genetic testing and screening for diseases like cancer and rare genetic disorders. The widespread application of genomic diagnostics in personalized medicine and healthcare systems makes it the leading segment. However, Consumer Genomics is the fastest-growing segment, fueled by the rising popularity of direct-to-consumer genetic testing kits that provide insights into ancestry, health risks, and wellness. The accessibility of these services, along with growing consumer interest in genetic health information, is accelerating its rapid expansion.

Genomics Market, By Products And Services

• Instruments And Equipment
• Consumables
• Software and Services

Based on Product and Services, the Global Genomics Market is segmented into Instruments and Equipment, Consumables, and Software and Services. The Consumables segment dominates due to the recurring demand for reagents, kits, and other supplies required in sequencing and genetic analysis. These consumables are essential for conducting research and diagnostics, driving their consistent use across laboratories, clinics, and research institutions. Meanwhile, the Software and Services segment is the fastest-growing, fueled by the increasing need for advanced data analysis tools to handle large genomic datasets and the rising adoption of cloud-based solutions, bioinformatics, and AI-driven platforms for personalized medicine and research applications.

Genomics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Genomics Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America holds the dominant position in the global genomics market, driven by advanced healthcare infrastructure, significant research funding, and a high adoption rate of genomics technologies. Asia Pacific is the fastest-growing region in the global genomics market, fueled by rapid advancements in healthcare infrastructure, government initiatives, and increased investments in research and development.

Key Players

• The "Global Genomics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
• llumina, Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation (Beckman Coulter), PerkinElmer, QIAGEN, BGI Group, Macrogen, and Oxford Nanopore Technologies.
• Our
• market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
• Genomics Market Recent Developments:
• In August 2023 Thermo Fisher Scientific completed the acquisition of The Binding Site Group, a leader in specialty diagnostics for blood cancer. This acquisition expands Thermo Fisher's genomics portfolio, enhancing its capabilities in clinical diagnostics and furthering its presence in personalized medicine.
• In July 2023 BGI Group, a leading genomics company, launched its latest high-throughput sequencing technology, "DNBSEQ-T7." This platform offers unprecedented speed and accuracy in genome sequencing, enabling more precise data for use in medical research and clinical applications.
• In June 2023 Roche announced a collaboration with its subsidiary Genentech to expand cancer genomics research. The partnership focuses on utilizing genomic data to develop targeted therapies for cancer patients, aiming to improve personalized treatment plans through comprehensive genetic profiling.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL GENOMICS MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL GENOMICS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL GENOMICS MARKET, BY TECHNOLOGY

• 5.1 Overview
• 5.2 Sequencing Technologies
• 5.3 Microarray Analysis
• 5.4 PCR
• 5.5 CRISPR

6 GLOBAL GENOMICS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Diagnostics
• 6.3 Drug Discovery and Development
• 6.4 Research
• 6.5 Agriculture And Livestock
• 6.6 Consumer Genomics

7 GLOBAL GENOMICS MARKET, BY PRODUCT AND SERVICES

• 7.1 Overview
• 7.2 Instruments And Equipment
• 7.3 Consumables
• 7.4 Software and Services

8 GLOBAL GENOMICS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL GENOMICS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 llumina
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Thermo Fisher Scientific
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Agilent Technologies
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 , Danaher Corporation (Beckman Coulter)
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 PerkinElmer
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 QIAGEN
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 BGI Group
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Macrogen
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Oxford Nanopore Technologies
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research